Founder and Chief Executive Officer
Chris Behrenbruch is a serial entrepreneur with a passion for developing and commercializing innovations in healthcare, life sciences and nanotechnology. He is currently Co-Founder and Chief Executive Officer of ImaginAb, a clinical stage biotechnology company based in Los Angeles and Singapore, and Chairman of Cell Therapies, a private-public partnership with the Peter MacCallum Cancer Center in Melbourne, Australia. Behrenbruch is also Co-Founder and Non-Executive Director of the Oncidium Foundation, a Brussels-based non-profit with the mission of developing cost-effective cancer treatments for the developing world. Behrenbruch completed his undergraduate studies at Monash University in Australia, earned a PhD in Biomedical Engineering from the University of Oxford and received an MBA jointly from New York University and the London School of Economics.